Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Science"
DOI: 10.1111/cas.15488
Abstract: Human leukocyte antigen class I (HLA‐I) genotypes are suggested to influence the cancer response to checkpoint blockade immunotherapy. This study assessed the impact of germline HLA genotypes on clinical outcomes in patients with chemoresistant advanced… read more here.
Keywords: outcomes patients; hla; treated pembrolizumab; hla genotypes ... See more keywords